Invokana Lawsuits On The Rise One Year Later

Last Updated on September 11, 2024

Invokana was approved by the FDA in 2013. Yet, in May 2016, a health and safety review was performed on Invokana and other SGLT2 inhibitors by Health Canada. The FDA followed suit a short time later because of the number of complaints and regarding cardiovascular problems, kidney damage, development of ketoacidosis, and strokes.

Invokana Lawsuits Filed Against Manufacturer

Invokana was once believed to be a drug that had great promise for diabetics. Yet, since the time it was approved by the FDA, the manufacturer, Janssen Pharmaceuticals, has been named as a defendant in an MDL being heard in federal court.

The number of Invokana lawsuits continues to rise a year after the health and safety review both in Canada and the United States. Allegations made against Janssen Pharmaceuticals include failure to warn patients adequately of the risks associated with Invokana, including kidney failure, ketoacidosis, and kidney damage; misrepresentation of the drug’s safety and side effects; failed to properly design and manufacturer Invokana; ignored studies related to its safety; and downplayed the seriousness of the side effects.

Health Canada’s Shocking Conclusion about Invokana

To highlight the serious nature of the Inovaka lawsuits, we would like to point out that they aren’t being filed only in the United States. There is an Invokana class action lawsuit filed in Canada seeking damages of $1B.

Health Canada performed a health and safety review of Invokana and concluded that “After reviewing a number of studies, it was found that type 2 diabetes patients taking SGLT2 inhibitors were more likely to experience diabetic ketoacidosis compared to those patients that were given a placebo or another type of drug that controls diabetes.” The study by Health Canada also noted an increase in other factors that cause diabetic ketoacidosis including major surgery or a serious infection.

Invokana Lawsuits Consolidated in the United States

In the United States, many of the Invokana lawsuits and lawsuits that name other SGLT2 inhibitors were recently consolidated under MDL. However, there are still more Invokana lawsuits being filed. MDL stands for multi-district litigation. This means that the Invokana lawsuits that were consolidated will have certain parts of the legal process that are shared. However, each case will still be heard regarding its own allegations and facts surrounding injuries or deaths related to the drug. The purpose of an MDL is to speed up certain aspects in an effort to better use the legal system.

Know the Signs of Ketoacidosis

Invokana has been linked to kidney problems, heart problems, a risk of stroke, and ketoacidosis. Although you should never stop your medication without first talking with your doctor, you should know the symptoms for all of them. Ketoacidosis is serious and may result in death. The signs of ketoacidosis often mimic many of the tell-tale sign of diabetes. They include:

• Excessive thirst
• Frequent urination
• Nausea
• Vomiting
• Abdominal pain
• Fatigue
• Shortness of breath
• Breath that smells like fruit
• Feelings of confusion
• Unusual ketone levels in your urine

Call your doctor right way or go to the nearest emergency room for help. Ketoacidosis is very serious and requires hospitalization.

Goldwater Law Firm

Goldwater Law Firm represents people who are hurt from taking a prescription medication. If you took Invokana and developed ketoacidosis, had a stroke, a heart attack, or were diagnosed with kidney disease, call Goldwater Law Firm right away. You may benefit from an Invokana lawsuit. To learn more, contact us and schedule your free case review.